Office of National Drug Control Policy Reauthorization Act of 2024
Latest Action
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Office of National Drug Control Policy Reauthorization Act of 2024 is a legislative proposal introduced in the House during the 118th Congress. It aims to reauthorize the Office of National Drug Control Policy (ONDCP), which coordinates federal drug control activities and policies. The bill was received in the Senate, read twice, and referred to the Committee on the Judiciary. However, the bill ultimately failed or expired without becoming law. Specific details about the bill's provisions, funding, or changes to existing law are not available in the provided data.
This bill sought to extend the authorization of the ONDCP but did not advance to enactment during the 118th Congress.
- The bill is titled the Office of National Drug Control Policy Reauthorization Act of 2024 and was introduced in the House of Representatives.
- Its primary purpose is to reauthorize the ONDCP, the federal agency responsible for coordinating drug control policies.
- The bill was referred to the Senate Judiciary Committee after being received in the Senate but did not pass into law.
['Office of National Drug Control Policy (ONDCP)', 'Federal agencies involved in drug control and law enforcement', 'Potentially communities affected by drug policy and enforcement efforts']
['Lack of detailed information on funding levels or new authorities limits assessment of fiscal impact or scope of changes.', 'Failure to pass may result in a lapse in formal reauthorization, potentially affecting agency operations or funding continuity.', 'Referral to the Judiciary Committee indicates oversight and policy review, but no further legislative progress was made.']
The bill was introduced in the House during the 118th Congress and referred to the Senate Judiciary Committee after initial consideration. The ONDCP is a longstanding federal office that requires periodic reauthorization by Congress. The failure or expiration of this bill means the ONDCP was not reauthorized through this legislative vehicle during this session.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential disruption or delay in coordinated federal drug control efforts if ONDCP operations are impacted by lack of reauthorization.', 'Uncertainty for agencies and stakeholders relying on ONDCP guidance and funding may affect planning and program implementation.']
The absence of a full bill text and official summary limits the ability to fully assess the scope and impact of this reauthorization effort. The failure to pass the bill raises concerns about the continuity of ONDCP's statutory authority and funding, which are critical for federal drug control coordination. Transparency in legislative documentation is essential for public oversight and informed debate.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.